公开(公告)号：US20230000845A1

公开(公告)日：2023-01-05

申请号：US17900235

申请日：2022-08-31

Applicant: RedHill Biopharma Ltd.

Inventor： Dror Ben-Asher ,  Reza Fathi ,  Mark Levitt ,  Ofra Barnett

IPC: A61K31/4409 ,  A61K9/48 ,  A61P31/14

Abstract: The disclosure is directed to ABC294640, as free base or as salts thereof, in preparing medicines for treating coronavirus infection or preventing diseases caused by coronavirus infection, and a medicine for preventing coronavirus infection or preventing diseases caused by coronavirus infection.

公开(公告)号：US12115150B2

公开(公告)日：2024-10-15

申请号：US17900235

申请日：2022-08-31

Applicant: RedHill Biopharma Ltd.

Inventor： Dror Ben-Asher ,  Reza Fathi ,  Mark Levitt ,  Ofra Barnett

IPC: A61K31/4409 ,  A61K9/48 ,  A61P31/14

CPC classification number: A61K31/4409 ,  A61K9/48 ,  A61P31/14

Abstract: The disclosure is directed to ABC294640, as free base or as salts thereof, in preparing medicines for treating coronavirus infection or preventing diseases caused by coronavirus infection, and a medicine for preventing coronavirus infection or preventing diseases caused by coronavirus infection.

公开(公告)号：US11471448B2

公开(公告)日：2022-10-18

申请号：US17552038

申请日：2021-12-15

Applicant: RedHill Biopharma Ltd.

Inventor： Dror Ben-Asher ,  Reza Fathi ,  Mark Levitt ,  Ofra Barnett

IPC: A61K31/4409 ,  A61K9/48 ,  A61P31/14

Abstract: The disclosure is directed to ABC294640, as free base or as salts thereof, in preparing medicines for treating coronavirus infection or preventing diseases caused by coronavirus infection, and a medicine for preventing coronavirus infection or preventing diseases caused by coronavirus infection.